631 results on '"Association of the British Pharmaceutical Industry"'
Search Results
2. LATEST COMPANY NEWS
3. Renewing the UK Voluntary Pricing Scheme: What does the 2024 VPAS mean for pharma?
4. ABPI RESPOND TO THE NEW NORTHERN IRELAND BREXIT DEAL
5. THE PRIME MINISTER CONFIRMED TODAY THAT THE NEW WINDSOR FRAMEWORK WOULD ENSURE MEDICINES APPROVED FOR USE BY THE UK REGULATOR WILL AUTOMATICALLY BECOME AVAILABLE IN NORTHERN IRELAND
6. ROUNDUP: SWISSMEDIC RESPONDS TO EU PAPER ON AVOIDING MEDICAL DEVICE SUPPLY DISRUPTIONS
7. Big pharma strikes blow to NHS patients' hopes of getting breakthrough drugs; Two major medical companies pull out of Britain's official pricing scheme at a time of soaring demand for treatment
8. Trial Decline
9. Association of the British Pharmaceutical Industry - ABPI - Pharmaceutical companies commit to new principles on using NHS data for research
10. Battle with Covid pushes Britain down medical research rankings
11. ABPI NORTHERN IRELAND MANIFESTO 2022
12. Adapting Regulations Post-Brexif: The UK government is taking advantage of the new regulatory flexibility, afforded by Brexit, to boost the country's competitiveness in pharma
13. ABPI RESPONSE TO THE LATEST NICE CONSULTATION
14. SPEECH: THE FUTURE OF UK MEDICINES AND VACCINES MANUFACTURING
15. ABPI RESPONSE TO UK GOVERNMENT 100M VACCINE PLEDGE
16. ABPI STATEMENT ON INTELLECTUAL PROPERTY RIGHTS FOR COVID-19 VACCINES
17. ABPI RESPONSE TO NEW GENOMICS FUNDING
18. ABPI RESPONSE TO NEW GLOBAL PARTNERSHIP TO FIGHT FUTURE PANDEMICS
19. ABPI RESPONSE TO NICE'S 5-YEAR STRATEGY
20. ABPI RESPONSE TO NHS COMMERCIAL FRAMEWORK
21. ABPI RESPONSE TO LIFE SCIENCE COMPETITIVENESS INDICATORS
22. ABPI comment on medicine export bans
23. ABPI COMMENT ON MEDICINE EXPORT BANS
24. ABPI RESPONSE TO UK COVID-19 VACCINES DELIVERY PLAN
25. ABPI RESPONSE TO COVID-19 BORDER CLOSURES SEVERAL COUNTRIES HAVE CLOSED THEIR BORDERS TO THE UK, INCLUDING FRANCE
26. ABPI RESPONSE TO THE SPENDING REVIEW
27. ABPI RESPONSE TO CONSULTATION ON NICE'S METHODS
28. A GLOBAL SCIENCE SUPERPOWER: THE FUTURE OF MEDICINES VALUATION
29. ABPI RESPONSE TO PM'S BREXIT COMMENTS
30. UK leads Europe in Phase I and Phase II trials, ABPI findings show
31. ABPI RESPONSE TO GOVERNMENT-SECURED BREXIT FREIGHT CAPACITY
32. ABPI calls on UK government to create non-COVID clinical research strategy
33. THE TASKFORCE FOR LUNG HEALTH SHOWS THAT COLLABORATION GETS RESULTS
34. ABPI RESPONSE TO NHS CONFEDERATION REPORTS: NHS RESET AND HEALTH INEQUALITIES
35. MHRA publishes guidance on medicine regulation after Brexit
36. ABPI RESPONSE TO MHRA GUIDANCE FOR THE END OF THE TRANSITION PERIOD
37. $1 BILLION ANTIBIOTICS RESEARCH FUND LAUNCHED BY PHARMACEUTICAL COMPANIES
38. Payments from UK pharma to healthcare professionals increased in 2019
39. PHARMACEUTICAL INDUSTRY INVESTS [pounds sterling]381 MILLION IN UK RANDD COLLABORATIONS - 2019 DATA ON DISCLOSURE UK
40. ABPI CONSULTS ON NEW-LOOK CODE OF PRACTICE
41. PUBLIC-PRIVATE ALLIANCE TO PROVIDE IMMUNISATION PROGRAMS FOR 300 MILLION CHILDREN GLOBALLY
42. GAVI: PARTNERING TO PROTECT FUTURE GENERATIONS FROM INFECTIOUS DISEASES
43. ABPI RESPONDS TO GOVERNMENT'S CORONAVIRUS TESTING 'CALL TO ARMS'
44. ABPI UPDATE ON THE PHARMACEUTICAL INDUSTRY'S RESPONSE TO CORONAVIRUS
45. PHARMACEUTICAL INDUSTRY RESPONSE TO BUDGET 2020
46. ABPI RESPONSE TO UK NEGOTIATING OBJECTIVES FOR US FTA
47. ABPI RESPONSE TO THE UK'S APPROACH TO EU NEGOTIATIONS
48. NOVARTIS HAS ANNOUNCED A COLLABORATION WITH NHS ENGLAND, THE NATIONAL INSTITUTE FOR HEALTH RESEARCH AND OXFORD UNIVERSITY
49. Professional societies and associations: interdisciplinary networking, publications, and conferences are a few of the benefits of society membership
50. ANALYSIS: WHAT DOES THE CONSERVATIVE GENERAL ELECTION MANIFESTO MEAN FOR US?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.